Recent Finacing
Recent Raise
Reneo Pharmaceuticals is a clinical-stage company developing REN001, an oral PPARδ agonist to enhance mitochondrial function and cellular energy for genetic mitochondrial disorders such as FAOD and PMM.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Reneo Pharmaceuticals.
